Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
- Update frequency
- every 5 days
- Episodes
- 347
- Years Active
- 2015 - 2025
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer.
Released July 28, 2017
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
FDA medical oncologists discuss the FDA approvals of brigatinib and ceritinib for ALK-positive non-small cell lung cancer.
Released July 25, 2017
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
FDA medical oncologists discuss the FDA approvals of brigatinib and ceritinib for ALK-positive non-small cell lung cancer.
Released July 25, 2017
Linking p53 Variation to Breast Cancer Risk in African American Women
It's widely known that genetics, family history, race, and other factors all play important roles in cancer risk. But what kinds of roles do they play, s…
Linking p53 Variation to Breast Cancer Risk in African American Women
It's widely known that genetics, family history, race, and other factors all play important roles in cancer risk. But what kinds of roles do they play, s…
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
The D.I.S.C.O. hosts discuss the agency’s first approval of pembrolizumab, a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated.
Released May…
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
The D.I.S.C.O. hosts discuss the agency’s first approval of pembrolizumab, a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated.
Released May…
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
Guest: Major Kenneth Lee, IV, MD, PhD
Though a relatively rare disease, pancreatic cancer remains at the forefront of clinical discussion due to its highly agg…
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
Guest: Major Kenneth Lee, IV, MD, PhD
Though a relatively rare disease, pancreatic cancer remains at the forefront of clinical discussion due to its highly agg…
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma.
Released May 22, 2017
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma.
Released May 22, 2017
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer…
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer…
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Several new screening tests have been developed to help doctors find colorectal cancer early when it's most treatable and can reduce the burden of this disease and t…
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Several new screening tests have been developed to help doctors find colorectal cancer early when it's most treatable and can reduce the burden of this disease and t…
Hot Topics in Breast Cancer Innovations
Guest: Ari Brooks, MD
Guest: Brian Englander, MD
Host Dr. Matt Birnholz is joined by Dr. Ari Brooks, Director of Endocrine and Oncology Surgery and Director …
Hot Topics in Breast Cancer Innovations
Guest: Ari Brooks, MD
Guest: Brian Englander, MD
Host Dr. Matt Birnholz is joined by Dr. Ari Brooks, Director of Endocrine and Oncology Surgery and Director …
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
Guest: Taine Pechet, MD
Dr. Taine Pechet, chief of surgery at Penn Presbyterian Medical Center and associate professor of clinical surgery at Penn Medicine joins…
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
Guest: Taine Pechet, MD
Dr. Taine Pechet, chief of surgery at Penn Presbyterian Medical Center and associate professor of clinical surgery at Penn Medicine joins…
High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management
Cannabis is gaining increased acceptance within the medical community for pain relief and other supportive care applications. But for oncology specialties, the use o…